Herman Awarded Donald C. Harrison Endowed Chair in Medicine
The year 2014 has been a memorable one for James Herman, PhD. In addition to being instrumental in the formation of the Neurobiology Research Center at the UC Neuroscience Institute and serving as its first director, Herman has been awarded the Donald C. Harrison Endowed Chair in Medicine in recognition of his outstanding contributions to neuroscience research.
Herman, a professor in the department of psychiatry and behavioral neuroscience, is based at UCs Reading Campus. His research focuses on stress pathways to the brain with particular emphasis on how stress contributes to psychiatric and neurologic pathologies (e.g., posttraumatic stress disorder and Parkinsons disease).
The Donald C. Harrison Endowed Chair in Medicine was established in 2008 by Donald Harrison, MD, senior vice president and provost for health affairs from 1986 to 2002. Randy Seeley, PhD, former professor of internal medicine in the division of endocrinology, previously held the chair.
"I would like to express my personal thanks to Dr. Harrison for his thoughtful gift to the University of Cincinnati, says Herman. "Its my intent to honor his generosity by continuing to perform cutting-edge basic research aimed at improving treatment, prevention and diagnosis of stress-related diseases.
"Dr. Herman is the ideal faculty member to receive this endowed chair, says Melanie Cushion, PhD, senior associate dean for research in the College of Medicine. "His research has made a significant impact in the area of stress, which has translated into national and international stature.
"Besides excellence as an investigator, he is a thoughtful and supportive mentor to many graduate students and younger faculty, Cushion adds. "The College of Medicine is very fortunate to have such a successful and respected faculty member.
Endowed chairs allow departments to recognize the work of excellent professors who are already part of the faculty, or create new programs and positions in areas of potential growth. They are a secure source of funding during times of financial change, or through the ebb and flow of national research funding.
Endowed chairs can honor donors or organizations, enabling the College of Medicine to provide enduring recognition for a gift. Unlike a donation to a general fund, endowed chairs provide permanent support for a faculty position. Approximately 5 percent of the funds market value is awarded each year to serve the purpose of the endowment.
Currently, the College of Medicine has a total of 71 functioning endowed chairs in place, with another 11 in the process of being funded, according to Mike Zenz, executive director of development and alumni affairs for the College of Medicine.
The UC Neurobiology Research Center was created in September 2014 as the 11th Center of Excellence within the UC Neuroscience Institute, a partnership of the College of Medicine and UC Health. Its goal, Herman says, is to create and nurture relationships between basic and clinical research, with a translational (bench to bedside) emphasis.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.